Takeo Murakawa
- Pharmacology top 2%
- Molecular Biology
- Molecular Medicine top 2%
- Infectious Diseases
- Public Health, Environmental and Occupational Health
- Co-authors
- Minoru NishidaMotohiro NishidaHiroshi SakamotoT MatsubaraYoshiko YokotaSachiko GotôShōgo KuwaharaToshiaki Kamimura
- Topics
- Antibiotics Pharmacokinetics and Efficacy (23 papers)Antibiotic Resistance in Bacteria (17 papers)Antimicrobial Resistance in Staphylococcus (7 papers)
- Cited by
- Molecular MedicinePharmacology
- Partner nations
- JapanUnited States
In The Last Decade
Takeo Murakawa
34 papers receiving 549 citations
Peers
Comparison fields: 5 of 85
- Pharmacology 371
- Molecular Biology 244
- Molecular Medicine 208
- Infectious Diseases 107
- Public Health, Environmental and Occupational Health 84
Countries citing papers authored by Takeo Murakawa
This map shows the geographic impact of Takeo Murakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeo Murakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeo Murakawa more than expected).
Fields of papers citing papers by Takeo Murakawa
This network shows the impact of papers produced by Takeo Murakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeo Murakawa. The network helps show where Takeo Murakawa may publish in the future.
Co-authorship network of co-authors of Takeo Murakawa
This figure shows the co-authorship network connecting the top 25 collaborators of Takeo Murakawa. A scholar is included among the top collaborators of Takeo Murakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeo Murakawa. Takeo Murakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | Fosmidomycin: a new phosphonic acid antibiotic. Part I: Phase I tolerance studies. | 25 |
| 3 | 4 | |
| 4 | 61 | |
| 5 | 12 | |
| 6 | 8 | |
| 7 | 36 | |
| 8 | 22 | |
| 9 | 2 | |
| 10 | 22 | |
| 11 | 16 | |
| 12 | 2 | |
| 13 | 7 | |
| 14 | 19 | |
| 15 | Cefazolin, a new semisynthetic cephalosporin antibiotic. 3. Absorption, excretion and tissue distribution in parenteral administration. | 35 |
| 16 | [Binding of penicillins and serum protein. 2. Relationship between blood protein binding of penicillins and incorporation into erythrocytes]. | 1 |
| 17 | 20 | |
| 18 | 6 | |
| 19 | In vitro and in vivo evaluation of cefazolin, a new cephalosporin C derivative. | 65 |
| 20 | 3 |
About Takeo Murakawa
Takeo Murakawa is a scholar working on Molecular Medicine, Pharmacology and Infectious Diseases, having authored 36 papers that have together received 658 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (23 papers), Antibiotic Resistance in Bacteria (17 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). The work is most often cited by research in Molecular Medicine (208 citations), Pharmacology (371 citations) and Pharmacology (66 citations). Takeo Murakawa has collaborated with scholars based in Japan and United States. Frequent co-authors include Minoru Nishida, Motohiro Nishida, Hiroshi Sakamoto, T Matsubara, Yoshiko Yokota, Sachiko Gotô, Shōgo Kuwahara, Toshiaki Kamimura, YASUHIRO MINE and Sandra Yasuyo Fukada. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The Journal of Antibiotics and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.